|
World Tuberculosis Day 2026
World Tuberculosis Day was observed on 24 March 2026 to raise awareness about tuberculosis and global efforts to eliminate it. The day highlights the disease burden and ongoing public health initiatives.
Tuberculosis and World Tuberculosis Day:
| Dimension | Key Details |
|---|---|
| Tuberculosis | Provides infectious disease caused by Mycobacterium tuberculosis |
| Types of TB | Comprises active TB with symptoms and transmission and latent TB without symptoms and non transmissible |
| Symptoms | Includes persistent cough chest pain fatigue weight loss and fever or night sweats |
| Transmission | Spreads through air when infected person coughs speaks or sings and does not spread through contact or surfaces |
| Risk Factors | Includes individuals with weakened immune systems such as HIV patients |
| Treatment | Provides antibiotic treatment for active TB for six to nine months and preventive treatment for latent TB |
| India Burden | India accounts for about 27 percent of global TB cases |
| World TB Day | Observed on 24 March to raise awareness about TB and its global impact |
| Historical Basis | Marks discovery of TB bacterium by Robert Koch in 1882 |
| Theme 2026 | Theme is Yes We Can End TB led by countries and powered by people |
| Coordinating Body | World Health Organization and Stop TB Partnership coordinate global efforts |
| Global Burden | 10.7 million cases and 1.23 million deaths reported worldwide in 2024 |
| TB Mukt Bharat Abhiyan | Provides national campaign to eliminate TB by 2025 |
| Nikshay Portal | Provides digital platform for TB patient management and monitoring |
| Nikshay Poshan Yojana | Provides nutritional support of 500 rupees per month to TB patients |
| Private Sector Role | Provides mandatory notification of TB cases by private practitioners |
| Community Measures | Includes awareness campaigns door to door screening and treatment adherence programs |
| Research Efforts | Includes adoption of new diagnostic tools and shorter drug regimens |
| Challenge | Drug resistant TB provides major challenge requiring improved innovation and adherence |